RetinalGenix Technologies (RTGN) Cash from Operations (2020 - 2026)
RetinalGenix Technologies' (RTGN) quarterly Cash from Operations came in at 109213.0 in Q1 2026, up 41.67% year-on-year from 77091.58 in Q1 2025, and up 14.82% quarter-over-quarter from 128219.0 in Q4 2025.
RetinalGenix Technologies (RTGN) Cash from Operations (2020 - 2026) Analysis & Trends
RetinalGenix Technologies has disclosed Cash from Operations across 7 years of filings, most recently posting 109213.0 for Q1 2026.
- Cash from Operations for Q1 2026 came in at 109213.0, up 41.67% year-over-year; the trailing twelve-month figure through Mar 2026 was 480341.0 (up 37.24% YoY), and the FY2025 annual result was 558350.0, up 24.74% from the prior year.
- Cash from Operations came in at 109213.0 for Q1 2026 at RetinalGenix Technologies, up from 128219.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 39749.0 in Q3 2023 to a low of 290025.0 in Q4 2023.
- The 5-year median for Cash from Operations is 123810.0 (2023), against an average of 121202.76.
- Peak annual rise in Cash from Operations reached 167.42% in 2023, while the deepest fall reached 1100.41% in 2023.
- RetinalGenix Technologies' Cash from Operations stood at 33225.0 in 2022, then plunged by 772.91% to 290025.0 in 2023, then jumped by 35.73% to 186390.0 in 2024, then soared by 31.21% to 128219.0 in 2025, then climbed by 14.82% to 109213.0 in 2026.
- The last three Cash from Operations figures came in at 109213.0 (Q1 2026), 128219.0 (Q4 2025), and 103837.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 1.32 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 581.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 2.74 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 348.00 Mn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 43.80 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 290.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 220.10 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 525.60 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 335.40 Mn |
| 10 | RetinalGenix Technologies | - | - | - | -109,213.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -109,213.00 |
| Mar 31, 2026 | -109,213.00 |
| Dec 31, 2025 | -128,219.00 |
| Dec 31, 2025 | -128,219.00 |
| Sep 30, 2025 | -103,837.00 |
| Sep 30, 2025 | -103,837.00 |
| Jun 30, 2025 | -139,072.00 |
| Jun 30, 2025 | -139,072.00 |
| Mar 31, 2025 | -187,222.00 |
| Mar 31, 2025 | -187,222.00 |
| Dec 31, 2024 | -186,390.00 |
| Dec 31, 2024 | -186,390.00 |
| Sep 30, 2024 | -246,932.00 |
| Sep 30, 2024 | -246,932.00 |
| Jun 30, 2024 | -144,795.00 |
| Jun 30, 2024 | -144,795.00 |
| Mar 31, 2024 | -163,819.00 |
| Mar 31, 2024 | -163,819.00 |
| Dec 31, 2023 | -290,025.00 |
| Dec 31, 2023 | -290,025.00 |